H.R. 10359IntroducedHouse · nowSenatePresidentLawIn committeeSec. 2 · H.R. 10359
Permanent extension of authority to award priority review vouchers for rare pediatric disease products
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
Section 529(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)) is amended by striking paragraph (5).